Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Coherus Oncology, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
145 institutional managers report a position in Coherus Oncology, Inc. worth $98.4M between them, filed on form 13F for the quarter ending 2026-06-30. 15 of them hold 80% of it, the largest being Timothy G. Youngquist 2020 Irrevocable Trust at 18.57%.
120 more managers in the register
15 managers hold 80% of the $98.4M institutional base. The other 130 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Samsara BioCapital, LLC, Alyeska Investment Group, L.P. · 4.88% of CHRS, 71.42% of KLRS
via Kohlberg Kravis Roberts & Co. L.P., Alyeska Investment Group, L.P., Hudson Bay Capital Management LP · 4.25% of CHRS, 28.96% of GMRS
via Samsara BioCapital, LLC, Panagora Asset Management Inc, Alyeska Investment Group, L.P. · 4.88% of CHRS, 5.90% of NKTX
via Samsara BioCapital, LLC, Alyeska Investment Group, L.P. · 4.88% of CHRS, 7.47% of IVA
via Samsara BioCapital, LLC, GSA Capital Partners LLP, Bridgeway Capital Management Inc · 4.88% of CHRS, 22.74% of RANI
via CM Management, LLC, Alyeska Investment Group, L.P. · 2.99% of CHRS, 5.12% of COYA
Managers holding a meaningful stake in CHRS also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
CHRS (Coherus Oncology, Inc.) has 3 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.